| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2023 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ZIOPHARM ONCOLOGY INC | 12 | Q3 2016 | 21.1% |
| INTREXON CORP | 12 | Q3 2016 | 13.1% |
| FACEBOOK INC | 12 | Q3 2016 | 3.4% |
| PIMCO DYNAMIC INCOME FD | 11 | Q3 2016 | 2.2% |
| SYNERGY PHARMACEUTICALS DEL | 11 | Q3 2016 | 1.4% |
| CBIZ INC | 11 | Q2 2016 | 0.2% |
| ZIOPHARM ONCOLOGY INC | 10 | Q3 2016 | 14.8% |
| LA JOLLA PHARMACEUTICAL CO | 10 | Q2 2016 | 3.4% |
| APPLE INC | 10 | Q3 2016 | 3.2% |
| MEDGENICS INC | 10 | Q2 2016 | 2.1% |
View Belmont Global Advisors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2016-11-14 |
| 13F-HR | 2016-08-15 |
| 13F-HR | 2016-05-16 |
| 13F-HR | 2016-02-16 |
| 13F-HR | 2015-11-16 |
| 13F-HR | 2015-08-14 |
| 13F-HR | 2015-05-15 |
| 13F-HR | 2015-02-17 |
| 13F-HR | 2014-11-14 |
| 13F-HR | 2014-08-14 |
View Belmont Global Advisors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.